nodes	percent_of_prediction	percent_of_DWPC	metapath
Acetazolamide—AQP1—skeletal joint—ankylosing spondylitis	0.129	0.465	CbGeAlD
Acetazolamide—AQP1—cartilage tissue—ankylosing spondylitis	0.087	0.313	CbGeAlD
Acetazolamide—SLC22A6—Methotrexate—ankylosing spondylitis	0.0518	0.22	CbGbCtD
Acetazolamide—CYP3A4—Methylprednisolone—ankylosing spondylitis	0.0455	0.193	CbGbCtD
Acetazolamide—CYP3A4—Triamcinolone—ankylosing spondylitis	0.0345	0.147	CbGbCtD
Acetazolamide—CYP3A4—Betamethasone—ankylosing spondylitis	0.0296	0.126	CbGbCtD
Acetazolamide—CYP3A4—Prednisolone—ankylosing spondylitis	0.0292	0.124	CbGbCtD
Acetazolamide—CYP3A4—Prednisone—ankylosing spondylitis	0.0276	0.117	CbGbCtD
Acetazolamide—Growth retardation—Methylprednisolone—ankylosing spondylitis	0.0225	0.0462	CcSEcCtD
Acetazolamide—Hepatic insufficiency—Methotrexate—ankylosing spondylitis	0.0218	0.0449	CcSEcCtD
Acetazolamide—Growth retardation—Betamethasone—ankylosing spondylitis	0.0204	0.042	CcSEcCtD
Acetazolamide—Growth retardation—Dexamethasone—ankylosing spondylitis	0.0204	0.042	CcSEcCtD
Acetazolamide—Growth retardation—Prednisone—ankylosing spondylitis	0.0178	0.0366	CcSEcCtD
Acetazolamide—CYP3A4—Dexamethasone—ankylosing spondylitis	0.0172	0.0731	CbGbCtD
Acetazolamide—AQP1—tendon—ankylosing spondylitis	0.0149	0.0535	CbGeAlD
Acetazolamide—Metabolic acidosis—Methylprednisolone—ankylosing spondylitis	0.0129	0.0265	CcSEcCtD
Acetazolamide—Electrolyte imbalance—Methylprednisolone—ankylosing spondylitis	0.0122	0.0251	CcSEcCtD
Acetazolamide—Electrolyte imbalance—Dexamethasone—ankylosing spondylitis	0.0111	0.0228	CcSEcCtD
Acetazolamide—Electrolyte imbalance—Betamethasone—ankylosing spondylitis	0.0111	0.0228	CcSEcCtD
Acetazolamide—CA3—tendon—ankylosing spondylitis	0.0109	0.0392	CbGeAlD
Acetazolamide—CA9—tendon—ankylosing spondylitis	0.0104	0.0375	CbGeAlD
Acetazolamide—Reaction gastrointestinal—Methotrexate—ankylosing spondylitis	0.0101	0.0208	CcSEcCtD
Acetazolamide—CA14—tendon—ankylosing spondylitis	0.00991	0.0356	CbGeAlD
Acetazolamide—CA5B—tendon—ankylosing spondylitis	0.00693	0.0249	CbGeAlD
Acetazolamide—Appetite absent—Methotrexate—ankylosing spondylitis	0.00679	0.014	CcSEcCtD
Acetazolamide—Tingling sensation—Methylprednisolone—ankylosing spondylitis	0.00635	0.0131	CcSEcCtD
Acetazolamide—Glycosuria—Triamcinolone—ankylosing spondylitis	0.00631	0.013	CcSEcCtD
Acetazolamide—Glycosuria—Methylprednisolone—ankylosing spondylitis	0.0063	0.013	CcSEcCtD
Acetazolamide—Tingling sensation—Dexamethasone—ankylosing spondylitis	0.00577	0.0119	CcSEcCtD
Acetazolamide—Tingling sensation—Betamethasone—ankylosing spondylitis	0.00577	0.0119	CcSEcCtD
Acetazolamide—Glycosuria—Dexamethasone—ankylosing spondylitis	0.00573	0.0118	CcSEcCtD
Acetazolamide—Glycosuria—Betamethasone—ankylosing spondylitis	0.00573	0.0118	CcSEcCtD
Acetazolamide—Glycosuria—Prednisone—ankylosing spondylitis	0.00499	0.0103	CcSEcCtD
Acetazolamide—CA4—tendon—ankylosing spondylitis	0.00479	0.0172	CbGeAlD
Acetazolamide—Anaphylactoid reaction—Prednisolone—ankylosing spondylitis	0.00417	0.00858	CcSEcCtD
Acetazolamide—CA2—tendon—ankylosing spondylitis	0.00397	0.0143	CbGeAlD
Acetazolamide—Anaphylactoid reaction—Triamcinolone—ankylosing spondylitis	0.00384	0.00789	CcSEcCtD
Acetazolamide—Anaphylactoid reaction—Methylprednisolone—ankylosing spondylitis	0.00383	0.00787	CcSEcCtD
Acetazolamide—Irritability—Methylprednisolone—ankylosing spondylitis	0.00354	0.00727	CcSEcCtD
Acetazolamide—Anaphylactoid reaction—Dexamethasone—ankylosing spondylitis	0.00348	0.00716	CcSEcCtD
Acetazolamide—Anaphylactoid reaction—Betamethasone—ankylosing spondylitis	0.00348	0.00716	CcSEcCtD
Acetazolamide—Melaena—Methotrexate—ankylosing spondylitis	0.0033	0.00678	CcSEcCtD
Acetazolamide—Irritability—Dexamethasone—ankylosing spondylitis	0.00322	0.00661	CcSEcCtD
Acetazolamide—Irritability—Betamethasone—ankylosing spondylitis	0.00322	0.00661	CcSEcCtD
Acetazolamide—Aplastic anaemia—Methotrexate—ankylosing spondylitis	0.00317	0.00652	CcSEcCtD
Acetazolamide—Hypokalaemia—Betamethasone—ankylosing spondylitis	0.00307	0.0063	CcSEcCtD
Acetazolamide—Hypokalaemia—Dexamethasone—ankylosing spondylitis	0.00307	0.0063	CcSEcCtD
Acetazolamide—Urine output increased—Methotrexate—ankylosing spondylitis	0.00305	0.00628	CcSEcCtD
Acetazolamide—Irritability—Prednisone—ankylosing spondylitis	0.0028	0.00576	CcSEcCtD
Acetazolamide—Photosensitivity—Methotrexate—ankylosing spondylitis	0.00279	0.00574	CcSEcCtD
Acetazolamide—Polyuria—Methotrexate—ankylosing spondylitis	0.00279	0.00574	CcSEcCtD
Acetazolamide—Hepatic failure—Methotrexate—ankylosing spondylitis	0.00273	0.00561	CcSEcCtD
Acetazolamide—Hypokalaemia—Prednisone—ankylosing spondylitis	0.00267	0.00549	CcSEcCtD
Acetazolamide—Anaphylactoid reaction—Methotrexate—ankylosing spondylitis	0.00253	0.00521	CcSEcCtD
Acetazolamide—Irritability—Methotrexate—ankylosing spondylitis	0.00234	0.00481	CcSEcCtD
Acetazolamide—Ataxia—Methotrexate—ankylosing spondylitis	0.00231	0.00474	CcSEcCtD
Acetazolamide—Ill-defined disorder—Prednisolone—ankylosing spondylitis	0.00226	0.00464	CcSEcCtD
Acetazolamide—Toxic epidermal necrolysis—Methotrexate—ankylosing spondylitis	0.00221	0.00454	CcSEcCtD
Acetazolamide—Malaise—Prednisolone—ankylosing spondylitis	0.00219	0.00451	CcSEcCtD
Acetazolamide—Dysgeusia—Triamcinolone—ankylosing spondylitis	0.00219	0.0045	CcSEcCtD
Acetazolamide—Convulsion—Prednisolone—ankylosing spondylitis	0.00211	0.00433	CcSEcCtD
Acetazolamide—Ill-defined disorder—Triamcinolone—ankylosing spondylitis	0.00207	0.00427	CcSEcCtD
Acetazolamide—Ill-defined disorder—Methylprednisolone—ankylosing spondylitis	0.00207	0.00426	CcSEcCtD
Acetazolamide—Discomfort—Prednisolone—ankylosing spondylitis	0.00205	0.00421	CcSEcCtD
Acetazolamide—Malaise—Triamcinolone—ankylosing spondylitis	0.00202	0.00415	CcSEcCtD
Acetazolamide—Malaise—Methylprednisolone—ankylosing spondylitis	0.00201	0.00414	CcSEcCtD
Acetazolamide—Anaphylactic shock—Prednisolone—ankylosing spondylitis	0.00198	0.00408	CcSEcCtD
Acetazolamide—Shock—Prednisolone—ankylosing spondylitis	0.00195	0.00401	CcSEcCtD
Acetazolamide—Convulsion—Triamcinolone—ankylosing spondylitis	0.00194	0.00398	CcSEcCtD
Acetazolamide—Photosensitivity reaction—Methotrexate—ankylosing spondylitis	0.00193	0.00398	CcSEcCtD
Acetazolamide—Convulsion—Methylprednisolone—ankylosing spondylitis	0.00193	0.00397	CcSEcCtD
Acetazolamide—Drowsiness—Methotrexate—ankylosing spondylitis	0.00189	0.00389	CcSEcCtD
Acetazolamide—Flushing—Prednisone—ankylosing spondylitis	0.00188	0.00387	CcSEcCtD
Acetazolamide—Ill-defined disorder—Betamethasone—ankylosing spondylitis	0.00188	0.00387	CcSEcCtD
Acetazolamide—Ill-defined disorder—Dexamethasone—ankylosing spondylitis	0.00188	0.00387	CcSEcCtD
Acetazolamide—Discomfort—Triamcinolone—ankylosing spondylitis	0.00188	0.00387	CcSEcCtD
Acetazolamide—Discomfort—Methylprednisolone—ankylosing spondylitis	0.00188	0.00386	CcSEcCtD
Acetazolamide—Stevens-Johnson syndrome—Methotrexate—ankylosing spondylitis	0.00187	0.00385	CcSEcCtD
Acetazolamide—Confusional state—Methylprednisolone—ankylosing spondylitis	0.00184	0.00377	CcSEcCtD
Acetazolamide—Malaise—Dexamethasone—ankylosing spondylitis	0.00183	0.00376	CcSEcCtD
Acetazolamide—Malaise—Betamethasone—ankylosing spondylitis	0.00183	0.00376	CcSEcCtD
Acetazolamide—Anaphylactic shock—Triamcinolone—ankylosing spondylitis	0.00183	0.00375	CcSEcCtD
Acetazolamide—Anaphylactic shock—Methylprednisolone—ankylosing spondylitis	0.00182	0.00374	CcSEcCtD
Acetazolamide—Haematuria—Methotrexate—ankylosing spondylitis	0.0018	0.0037	CcSEcCtD
Acetazolamide—Shock—Triamcinolone—ankylosing spondylitis	0.0018	0.00369	CcSEcCtD
Acetazolamide—Shock—Methylprednisolone—ankylosing spondylitis	0.00179	0.00368	CcSEcCtD
Acetazolamide—Hepatobiliary disease—Methotrexate—ankylosing spondylitis	0.00179	0.00367	CcSEcCtD
Acetazolamide—Paraesthesia—Prednisolone—ankylosing spondylitis	0.00178	0.00366	CcSEcCtD
Acetazolamide—Agranulocytosis—Methotrexate—ankylosing spondylitis	0.00176	0.00363	CcSEcCtD
Acetazolamide—Convulsion—Betamethasone—ankylosing spondylitis	0.00176	0.00361	CcSEcCtD
Acetazolamide—Convulsion—Dexamethasone—ankylosing spondylitis	0.00176	0.00361	CcSEcCtD
Acetazolamide—Discomfort—Dexamethasone—ankylosing spondylitis	0.00171	0.00351	CcSEcCtD
Acetazolamide—Discomfort—Betamethasone—ankylosing spondylitis	0.00171	0.00351	CcSEcCtD
Acetazolamide—Anaphylactic shock—Betamethasone—ankylosing spondylitis	0.00166	0.0034	CcSEcCtD
Acetazolamide—Anaphylactic shock—Dexamethasone—ankylosing spondylitis	0.00166	0.0034	CcSEcCtD
Acetazolamide—Ill-defined disorder—Prednisone—ankylosing spondylitis	0.00164	0.00337	CcSEcCtD
Acetazolamide—Paraesthesia—Triamcinolone—ankylosing spondylitis	0.00164	0.00337	CcSEcCtD
Acetazolamide—Feeling abnormal—Prednisolone—ankylosing spondylitis	0.00164	0.00336	CcSEcCtD
Acetazolamide—Paraesthesia—Methylprednisolone—ankylosing spondylitis	0.00164	0.00336	CcSEcCtD
Acetazolamide—Shock—Dexamethasone—ankylosing spondylitis	0.00163	0.00335	CcSEcCtD
Acetazolamide—Shock—Betamethasone—ankylosing spondylitis	0.00163	0.00335	CcSEcCtD
Acetazolamide—Agitation—Prednisone—ankylosing spondylitis	0.00162	0.00334	CcSEcCtD
Acetazolamide—Thrombocytopenia—Betamethasone—ankylosing spondylitis	0.00162	0.00333	CcSEcCtD
Acetazolamide—Thrombocytopenia—Dexamethasone—ankylosing spondylitis	0.00162	0.00333	CcSEcCtD
Acetazolamide—Dyspepsia—Triamcinolone—ankylosing spondylitis	0.00161	0.0033	CcSEcCtD
Acetazolamide—Erythema multiforme—Methotrexate—ankylosing spondylitis	0.0016	0.0033	CcSEcCtD
Acetazolamide—Dyspepsia—Methylprednisolone—ankylosing spondylitis	0.0016	0.0033	CcSEcCtD
Acetazolamide—Malaise—Prednisone—ankylosing spondylitis	0.00159	0.00328	CcSEcCtD
Acetazolamide—Tinnitus—Methotrexate—ankylosing spondylitis	0.00158	0.00325	CcSEcCtD
Acetazolamide—Urticaria—Prednisolone—ankylosing spondylitis	0.00158	0.00324	CcSEcCtD
Acetazolamide—Fatigue—Triamcinolone—ankylosing spondylitis	0.00157	0.00323	CcSEcCtD
Acetazolamide—Fatigue—Methylprednisolone—ankylosing spondylitis	0.00157	0.00323	CcSEcCtD
Acetazolamide—Convulsion—Prednisone—ankylosing spondylitis	0.00153	0.00315	CcSEcCtD
Acetazolamide—Feeling abnormal—Triamcinolone—ankylosing spondylitis	0.0015	0.00309	CcSEcCtD
Acetazolamide—Feeling abnormal—Methylprednisolone—ankylosing spondylitis	0.0015	0.00309	CcSEcCtD
Acetazolamide—Paraesthesia—Dexamethasone—ankylosing spondylitis	0.00149	0.00306	CcSEcCtD
Acetazolamide—Paraesthesia—Betamethasone—ankylosing spondylitis	0.00149	0.00306	CcSEcCtD
Acetazolamide—Discomfort—Prednisone—ankylosing spondylitis	0.00149	0.00306	CcSEcCtD
Acetazolamide—Dyspepsia—Betamethasone—ankylosing spondylitis	0.00146	0.003	CcSEcCtD
Acetazolamide—Dyspepsia—Dexamethasone—ankylosing spondylitis	0.00146	0.003	CcSEcCtD
Acetazolamide—Urticaria—Triamcinolone—ankylosing spondylitis	0.00145	0.00298	CcSEcCtD
Acetazolamide—Urticaria—Methylprednisolone—ankylosing spondylitis	0.00145	0.00297	CcSEcCtD
Acetazolamide—Dysgeusia—Methotrexate—ankylosing spondylitis	0.00145	0.00297	CcSEcCtD
Acetazolamide—Body temperature increased—Triamcinolone—ankylosing spondylitis	0.00144	0.00297	CcSEcCtD
Acetazolamide—Anaphylactic shock—Prednisone—ankylosing spondylitis	0.00144	0.00296	CcSEcCtD
Acetazolamide—Decreased appetite—Dexamethasone—ankylosing spondylitis	0.00144	0.00296	CcSEcCtD
Acetazolamide—Decreased appetite—Betamethasone—ankylosing spondylitis	0.00144	0.00296	CcSEcCtD
Acetazolamide—Gastrointestinal disorder—Dexamethasone—ankylosing spondylitis	0.00143	0.00294	CcSEcCtD
Acetazolamide—Gastrointestinal disorder—Betamethasone—ankylosing spondylitis	0.00143	0.00294	CcSEcCtD
Acetazolamide—Fatigue—Betamethasone—ankylosing spondylitis	0.00143	0.00294	CcSEcCtD
Acetazolamide—Fatigue—Dexamethasone—ankylosing spondylitis	0.00143	0.00294	CcSEcCtD
Acetazolamide—Shock—Prednisone—ankylosing spondylitis	0.00142	0.00292	CcSEcCtD
Acetazolamide—Ill-defined disorder—Methotrexate—ankylosing spondylitis	0.00137	0.00282	CcSEcCtD
Acetazolamide—Feeling abnormal—Dexamethasone—ankylosing spondylitis	0.00136	0.00281	CcSEcCtD
Acetazolamide—Feeling abnormal—Betamethasone—ankylosing spondylitis	0.00136	0.00281	CcSEcCtD
Acetazolamide—Malaise—Methotrexate—ankylosing spondylitis	0.00133	0.00274	CcSEcCtD
Acetazolamide—Leukopenia—Methotrexate—ankylosing spondylitis	0.00132	0.00272	CcSEcCtD
Acetazolamide—Urticaria—Dexamethasone—ankylosing spondylitis	0.00132	0.0027	CcSEcCtD
Acetazolamide—Urticaria—Betamethasone—ankylosing spondylitis	0.00132	0.0027	CcSEcCtD
Acetazolamide—Dizziness—Prednisolone—ankylosing spondylitis	0.00131	0.0027	CcSEcCtD
Acetazolamide—Asthenia—Triamcinolone—ankylosing spondylitis	0.00131	0.00269	CcSEcCtD
Acetazolamide—Body temperature increased—Dexamethasone—ankylosing spondylitis	0.00131	0.00269	CcSEcCtD
Acetazolamide—Body temperature increased—Betamethasone—ankylosing spondylitis	0.00131	0.00269	CcSEcCtD
Acetazolamide—Asthenia—Methylprednisolone—ankylosing spondylitis	0.00131	0.00269	CcSEcCtD
Acetazolamide—Paraesthesia—Prednisone—ankylosing spondylitis	0.0013	0.00266	CcSEcCtD
Acetazolamide—Convulsion—Methotrexate—ankylosing spondylitis	0.00128	0.00263	CcSEcCtD
Acetazolamide—Dyspepsia—Prednisone—ankylosing spondylitis	0.00127	0.00261	CcSEcCtD
Acetazolamide—Decreased appetite—Prednisone—ankylosing spondylitis	0.00125	0.00258	CcSEcCtD
Acetazolamide—Diarrhoea—Methylprednisolone—ankylosing spondylitis	0.00125	0.00256	CcSEcCtD
Acetazolamide—Fatigue—Prednisone—ankylosing spondylitis	0.00124	0.00256	CcSEcCtD
Acetazolamide—Headache—Prednisolone—ankylosing spondylitis	0.00124	0.00256	CcSEcCtD
Acetazolamide—Discomfort—Methotrexate—ankylosing spondylitis	0.00124	0.00255	CcSEcCtD
Acetazolamide—Confusional state—Methotrexate—ankylosing spondylitis	0.00122	0.0025	CcSEcCtD
Acetazolamide—Dizziness—Triamcinolone—ankylosing spondylitis	0.00121	0.00248	CcSEcCtD
Acetazolamide—Anaphylactic shock—Methotrexate—ankylosing spondylitis	0.00121	0.00248	CcSEcCtD
Acetazolamide—Dizziness—Methylprednisolone—ankylosing spondylitis	0.0012	0.00248	CcSEcCtD
Acetazolamide—Feeling abnormal—Prednisone—ankylosing spondylitis	0.00119	0.00244	CcSEcCtD
Acetazolamide—Asthenia—Dexamethasone—ankylosing spondylitis	0.00119	0.00244	CcSEcCtD
Acetazolamide—Asthenia—Betamethasone—ankylosing spondylitis	0.00119	0.00244	CcSEcCtD
Acetazolamide—Thrombocytopenia—Methotrexate—ankylosing spondylitis	0.00118	0.00243	CcSEcCtD
Acetazolamide—Nausea—Prednisolone—ankylosing spondylitis	0.00118	0.00242	CcSEcCtD
Acetazolamide—Vomiting—Triamcinolone—ankylosing spondylitis	0.00116	0.00239	CcSEcCtD
Acetazolamide—Vomiting—Methylprednisolone—ankylosing spondylitis	0.00116	0.00238	CcSEcCtD
Acetazolamide—Urticaria—Prednisone—ankylosing spondylitis	0.00115	0.00236	CcSEcCtD
Acetazolamide—Headache—Triamcinolone—ankylosing spondylitis	0.00114	0.00235	CcSEcCtD
Acetazolamide—Headache—Methylprednisolone—ankylosing spondylitis	0.00114	0.00235	CcSEcCtD
Acetazolamide—Body temperature increased—Prednisone—ankylosing spondylitis	0.00114	0.00234	CcSEcCtD
Acetazolamide—Diarrhoea—Dexamethasone—ankylosing spondylitis	0.00113	0.00233	CcSEcCtD
Acetazolamide—Diarrhoea—Betamethasone—ankylosing spondylitis	0.00113	0.00233	CcSEcCtD
Acetazolamide—Dizziness—Dexamethasone—ankylosing spondylitis	0.0011	0.00225	CcSEcCtD
Acetazolamide—Dizziness—Betamethasone—ankylosing spondylitis	0.0011	0.00225	CcSEcCtD
Acetazolamide—Nausea—Triamcinolone—ankylosing spondylitis	0.00108	0.00223	CcSEcCtD
Acetazolamide—Paraesthesia—Methotrexate—ankylosing spondylitis	0.00108	0.00222	CcSEcCtD
Acetazolamide—Nausea—Methylprednisolone—ankylosing spondylitis	0.00108	0.00222	CcSEcCtD
Acetazolamide—Somnolence—Methotrexate—ankylosing spondylitis	0.00107	0.0022	CcSEcCtD
Acetazolamide—Dyspepsia—Methotrexate—ankylosing spondylitis	0.00106	0.00218	CcSEcCtD
Acetazolamide—Vomiting—Dexamethasone—ankylosing spondylitis	0.00105	0.00216	CcSEcCtD
Acetazolamide—Vomiting—Betamethasone—ankylosing spondylitis	0.00105	0.00216	CcSEcCtD
Acetazolamide—Decreased appetite—Methotrexate—ankylosing spondylitis	0.00105	0.00215	CcSEcCtD
Acetazolamide—Gastrointestinal disorder—Methotrexate—ankylosing spondylitis	0.00104	0.00214	CcSEcCtD
Acetazolamide—Fatigue—Methotrexate—ankylosing spondylitis	0.00104	0.00214	CcSEcCtD
Acetazolamide—Headache—Dexamethasone—ankylosing spondylitis	0.00104	0.00213	CcSEcCtD
Acetazolamide—Headache—Betamethasone—ankylosing spondylitis	0.00104	0.00213	CcSEcCtD
Acetazolamide—Asthenia—Prednisone—ankylosing spondylitis	0.00103	0.00213	CcSEcCtD
Acetazolamide—Feeling abnormal—Methotrexate—ankylosing spondylitis	0.000993	0.00204	CcSEcCtD
Acetazolamide—Diarrhoea—Prednisone—ankylosing spondylitis	0.000987	0.00203	CcSEcCtD
Acetazolamide—Nausea—Betamethasone—ankylosing spondylitis	0.000984	0.00202	CcSEcCtD
Acetazolamide—Nausea—Dexamethasone—ankylosing spondylitis	0.000984	0.00202	CcSEcCtD
Acetazolamide—Urticaria—Methotrexate—ankylosing spondylitis	0.000958	0.00197	CcSEcCtD
Acetazolamide—Dizziness—Prednisone—ankylosing spondylitis	0.000954	0.00196	CcSEcCtD
Acetazolamide—Body temperature increased—Methotrexate—ankylosing spondylitis	0.000953	0.00196	CcSEcCtD
Acetazolamide—Vomiting—Prednisone—ankylosing spondylitis	0.000917	0.00189	CcSEcCtD
Acetazolamide—Headache—Prednisone—ankylosing spondylitis	0.000903	0.00186	CcSEcCtD
Acetazolamide—Asthenia—Methotrexate—ankylosing spondylitis	0.000865	0.00178	CcSEcCtD
Acetazolamide—Nausea—Prednisone—ankylosing spondylitis	0.000857	0.00176	CcSEcCtD
Acetazolamide—Diarrhoea—Methotrexate—ankylosing spondylitis	0.000825	0.0017	CcSEcCtD
Acetazolamide—Dizziness—Methotrexate—ankylosing spondylitis	0.000797	0.00164	CcSEcCtD
Acetazolamide—Vomiting—Methotrexate—ankylosing spondylitis	0.000766	0.00158	CcSEcCtD
Acetazolamide—Headache—Methotrexate—ankylosing spondylitis	0.000755	0.00155	CcSEcCtD
Acetazolamide—Nausea—Methotrexate—ankylosing spondylitis	0.000716	0.00147	CcSEcCtD
